View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

Mexico's Neolpharma opens R&D facility in Puerto Rico

The Center for the Development and Innovation of Pharmaceutical Products, or Cediprof, will focus on research and experimentation of generic drugs.
Read More

Another Ranbaxy facility lands on FDA blacklist

The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More

Israel's Teva to buy NuPathe for $144 million

Pennsylvania-based NuPathe specializes in therapeutics for diseases of the central nervous system (CNS), including neurological and psychiatric disorders.
Read More

Novo Nordisk locked in legal battle over generic drug

Danish pharmaceutical giant Novo Nordisk is being sued by several healthcare purchasing companies that claim the drug maker wrongfully kept generic copies of its diabetes drug Prandin off the market.
Read More

US pharmaceutical spending slightly down from 2012 levels

Expenditure on pharmaceuticals in 2013 is predicted to register a minor decline of 0.5% dipping to $341.2 billion from $343 billion in 2012.
Read More

US, European watchdogs join forces to regulate generic drugs

The European Medicines Agency and the U.S. Food and Drug Administration have started a joint program for sharing information on bioequivalence studies required during the process of approval for generic drugs.
Read More

FDA tightens grip on Indian drug makers

The U.S. Food and Drug Administration (FDA) has warned two Indian pharmaceutical companies over suspected breaches of good manufacturing practices.
Read More

Chinese pharma probe spreads to two Danish drug makers

Western pharmaceutical companies are coming under increased scrutiny in China following the bribery accusations leveled last month against GlaxoSmithKline (GSK).
Read More

European biotechs back on venture capital radar

Venture capital firms are once again warming to European biotechnology players, which attracted a significant portion of the venture capital invested globally in this sector during the second quarter.
Read More

Generic drug patent settlements cut costs for health systems, study finds

The U.S. health system saved a total of $25.5 billion between 2005 and 2012 thanks to generic drugs being launched on the market before patent expirations as a result of patent settlements.
Read More